Reply to "High Pharmacokinetic Variability and Unrecognized Limitations in First-Line Osimertinib Plus Chemotherapy for EGFR-Mutated NSCLC".

Authors

Azar Shahraz, Jincheng Yang, Diansong Zhou, Karthick Vishwanathan, Dana Ghiorghiu, Yuri Rukazenkov, Aarti Sawant-Basak

Published in

Clinical pharmacology and therapeutics. Sep 16, 2025. Epub Sep 16, 2025.

PMID:
40955549
Bibliographic data and abstract were imported from PubMed on 16 Sep 2025.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.